These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7001776)

  • 21. The circadian pattern of ischaemic heart disease events in Indian population.
    Mehta SR; Das S; Karloopia SD; Mathur P; Dham SK; Ranganathan D
    J Assoc Physicians India; 1998 Sep; 46(9):767-71. PubMed ID: 11229243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary prevention of coronary heart disease in childhood].
    Richter H
    Cor Vasa; 1981; 23(1):21-7. PubMed ID: 7238051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments.
    De Lorgeril M; Salen P; Martin JL; Mamelle N; Monjaud I; Touboul P; Delaye J
    J Am Coll Cardiol; 1996 Nov; 28(5):1103-8. PubMed ID: 8890801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid hormones and the heart].
    Zyśko D
    Pol Merkur Lekarski; 1999 Mar; 6(33):157-60. PubMed ID: 10365603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular effects of replacement hormones].
    Kornitzer M; Hindlet JY
    Rev Med Brux; 1995; 16(4):285-90. PubMed ID: 7481244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circadian patterns of ischemic events].
    Cafagna D; Ponte E
    Minerva Med; 1996 Oct; 87(10):455-64. PubMed ID: 8992407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiovascular risk factors in the circadian rhythm of acute myocardial infarction].
    López Messa JB; Garmendia Leiza JR; Aguilar García MD; Andrés de Llano JM; Alberola López C; Ardura Fernández J;
    Rev Esp Cardiol; 2004 Sep; 57(9):850-8. PubMed ID: 15373991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with thyroid hormones with special reference to coronary disease].
    Pfannenstiel P; Maier R
    Z Gesamte Inn Med; 1980 May; 35(10):426-9. PubMed ID: 7434832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular effects of thyroid hormones].
    Mohr-Kahaly S; Kahaly G; Meyer J
    Z Kardiol; 1996; 85 Suppl 6():219-31. PubMed ID: 9064969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the diastole time of the human heart as influenced by 4-6 weeks of physical training in ischemic heart disease].
    Jordan H
    Z Gesamte Inn Med; 1980 Apr; 35(7):309-12. PubMed ID: 7405323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arteriosclerosis, coronary heart disease and physical activity].
    Dawidowicz A
    Wiad Lek; 1971 Oct; 24(20):1911-5. PubMed ID: 4943965
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromoendocrinological studies in athletes. IV. Multiple hormonal responses to submaximal muscular exercise.
    Dobrzański T; Zurowski S; Graban W
    Acta Physiol Pol; 1981; 32(5):529-36. PubMed ID: 7039227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine glia: roles of glial cells in the brain actions of steroid and thyroid hormones and in the regulation of hormone secretion.
    Garcia-Segura LM; Chowen JA; Naftolin F
    Front Neuroendocrinol; 1996 Apr; 17(2):180-211. PubMed ID: 8812295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary prevention in acute myocardial infarction].
    Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
    Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.